Request for Covid-19 Impact Assessment of this Report
Scope of the Report:
This report focuses on the Inhalable Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Global inhalable drugs market is expected to witness a lucrative market growth over the forecast period owing to rising prevalence of chronic diseases such as diabetes mellitus, tuberculosis, cancer and increasing geriatric population base which requires more convenient route of administration.
The worldwide market for Inhalable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
NanoDerma
Pfizer
Aradigm Corporation
Alkerme
Dura Pharmaceuticals
AeroGen and Inhale Therapeutic Systems
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
Market Segment by Applications, can be divided into
Respiratory diseases
Non-respiratory diseases
There are 15 Chapters to deeply display the global Inhalable Drugs market.
Chapter 1, to describe Inhalable Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Inhalable Drugs, with sales, revenue, and price of Inhalable Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Inhalable Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Inhalable Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Inhalable Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview
1.1 Inhalable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Suspension Aerosol
1.2.2 Solution Aerosol
1.2.3 Dry Powder Formulation
1.3 Market Analysis by Applications
1.3.1 Respiratory diseases
1.3.2 Non-respiratory diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 NanoDerma
2.1.1 Business Overview
2.1.2 Inhalable Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 NanoDerma Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Inhalable Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Aradigm Corporation
2.3.1 Business Overview
2.3.2 Inhalable Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aradigm Corporation Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Alkerme
2.4.1 Business Overview
2.4.2 Inhalable Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alkerme Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dura Pharmaceuticals
2.5.1 Business Overview
2.5.2 Inhalable Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dura Pharmaceuticals Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AeroGen and Inhale Therapeutic Systems
2.6.1 Business Overview
2.6.2 Inhalable Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Inhalable Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Inhalable Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Inhalable Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Inhalable Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Inhalable Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Inhalable Drugs Market Analysis by Regions
4.1 Global Inhalable Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Inhalable Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Inhalable Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Inhalable Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Inhalable Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Inhalable Drugs Sales and Growth Rate (2013-2018)
4.5 South America Inhalable Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Inhalable Drugs Sales and Growth Rate (2013-2018)
5 North America Inhalable Drugs by Countries
5.1 North America Inhalable Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Inhalable Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Inhalable Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Inhalable Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Inhalable Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Inhalable Drugs Sales and Growth Rate (2013-2018)
6 Europe Inhalable Drugs by Countries
6.1 Europe Inhalable Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Inhalable Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Inhalable Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Inhalable Drugs Sales and Growth Rate (2013-2018)
6.3 UK Inhalable Drugs Sales and Growth Rate (2013-2018)
6.4 France Inhalable Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Inhalable Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Inhalable Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Inhalable Drugs by Countries
7.1 Asia-Pacific Inhalable Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Inhalable Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Inhalable Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Inhalable Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Inhalable Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Inhalable Drugs Sales and Growth Rate (2013-2018)
7.5 India Inhalable Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Inhalable Drugs Sales and Growth Rate (2013-2018)
8 South America Inhalable Drugs by Countries
8.1 South America Inhalable Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Inhalable Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Inhalable Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Inhalable Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Inhalable Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Inhalable Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Inhalable Drugs by Countries
9.1 Middle East and Africa Inhalable Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Inhalable Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Inhalable Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Inhalable Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Inhalable Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Inhalable Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Inhalable Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Inhalable Drugs Sales and Growth Rate (2013-2018)
10 Global Inhalable Drugs Market Segment by Type
10.1 Global Inhalable Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Inhalable Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Inhalable Drugs Revenue and Market Share by Type (2013-2018)
10.2 Suspension Aerosol Sales Growth and Price
10.2.1 Global Suspension Aerosol Sales Growth (2013-2018)
10.2.2 Global Suspension Aerosol Price (2013-2018)
10.3 Solution Aerosol Sales Growth and Price
10.3.1 Global Solution Aerosol Sales Growth (2013-2018)
10.3.2 Global Solution Aerosol Price (2013-2018)
10.4 Dry Powder Formulation Sales Growth and Price
10.4.1 Global Dry Powder Formulation Sales Growth (2013-2018)
10.4.2 Global Dry Powder Formulation Price (2013-2018)
11 Global Inhalable Drugs Market Segment by Application
11.1 Global Inhalable Drugs Sales Market Share by Application (2013-2018)
11.2 Respiratory diseases Sales Growth (2013-2018)
11.3 Non-respiratory diseases Sales Growth (2013-2018)
12 Inhalable Drugs Market Forecast (2018-2023)
12.1 Global Inhalable Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Inhalable Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Inhalable Drugs Market Forecast (2018-2023)
12.2.2 Europe Inhalable Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Inhalable Drugs Market Forecast (2018-2023)
12.2.4 South America Inhalable Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Inhalable Drugs Market Forecast (2018-2023)
12.3 Inhalable Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Inhalable Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Inhalable Drugs Market Share Forecast by Type (2018-2023)
12.4 Inhalable Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Inhalable Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Inhalable Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Inhalable Drugs Picture
Table Product Specifications of Inhalable Drugs
Figure Global Sales Market Share of Inhalable Drugs by Types in 2017
Table Inhalable Drugs Types for Major Manufacturers
Figure Suspension Aerosol Picture
Figure Solution Aerosol Picture
Figure Dry Powder Formulation Picture
Figure Inhalable Drugs Sales Market Share by Applications in 2017
Figure Respiratory diseases Picture
Figure Non-respiratory diseases Picture
Figure United States Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Inhalable Drugs Revenue (Value) and Growth Rate (2013-2023)
Table NanoDerma Basic Information, Manufacturing Base and Competitors
Table NanoDerma Inhalable Drugs Type and Applications
Table NanoDerma Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Inhalable Drugs Type and Applications
Table Pfizer Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aradigm Corporation Basic Information, Manufacturing Base and Competitors
Table Aradigm Corporation Inhalable Drugs Type and Applications
Table Aradigm Corporation Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alkerme Basic Information, Manufacturing Base and Competitors
Table Alkerme Inhalable Drugs Type and Applications
Table Alkerme Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dura Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Dura Pharmaceuticals Inhalable Drugs Type and Applications
Table Dura Pharmaceuticals Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AeroGen and Inhale Therapeutic Systems Basic Information, Manufacturing Base and Competitors
Table AeroGen and Inhale Therapeutic Systems Inhalable Drugs Type and Applications
Table AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Inhalable Drugs Sales by Manufacturer (2016-2017)
Figure Global Inhalable Drugs Sales Market Share by Manufacturer in 2016
Figure Global Inhalable Drugs Sales Market Share by Manufacturer in 2017
Table Global Inhalable Drugs Revenue by Manufacturer (2016-2017)
Figure Global Inhalable Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Inhalable Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Inhalable Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Inhalable Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Global Inhalable Drugs Revenue and Growth Rate (2013-2018)
Table Global Inhalable Drugs Sales by Regions (2013-2018)
Table Global Inhalable Drugs Sales Market Share by Regions (2013-2018)
Table Global Inhalable Drugs Revenue by Regions (2013-2018)
Figure Global Inhalable Drugs Revenue Market Share by Regions in 2013
Figure Global Inhalable Drugs Revenue Market Share by Regions in 2017
Figure North America Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Europe Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure South America Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure North America Inhalable Drugs Revenue and Growth Rate (2013-2018)
Table North America Inhalable Drugs Sales by Countries (2013-2018)
Table North America Inhalable Drugs Sales Market Share by Countries (2013-2018)
Figure North America Inhalable Drugs Sales Market Share by Countries in 2013
Figure North America Inhalable Drugs Sales Market Share by Countries in 2017
Table North America Inhalable Drugs Revenue by Countries (2013-2018)
Table North America Inhalable Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Inhalable Drugs Revenue Market Share by Countries in 2013
Figure North America Inhalable Drugs Revenue Market Share by Countries in 2017
Figure United States Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Canada Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Europe Inhalable Drugs Revenue and Growth Rate (2013-2018)
Table Europe Inhalable Drugs Sales by Countries (2013-2018)
Table Europe Inhalable Drugs Sales Market Share by Countries (2013-2018)
Table Europe Inhalable Drugs Revenue by Countries (2013-2018)
Figure Europe Inhalable Drugs Revenue Market Share by Countries in 2016
Figure Europe Inhalable Drugs Revenue Market Share by Countries in 2017
Figure Germany Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure UK Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure France Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Russia Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Italy Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Inhalable Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Inhalable Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Inhalable Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Inhalable Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Inhalable Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Inhalable Drugs Revenue Market Share by Countries 2017
Figure China Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Japan Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Korea Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure India Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure South America Inhalable Drugs Revenue and Growth Rate (2013-2018)
Table South America Inhalable Drugs Sales by Countries (2013-2018)
Table South America Inhalable Drugs Sales Market Share by Countries (2013-2018)
Figure South America Inhalable Drugs Sales Market Share by Countries in 2017
Table South America Inhalable Drugs Revenue by Countries (2013-2018)
Table South America Inhalable Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Inhalable Drugs Revenue Market Share by Countries in 2017
Figure Brazil Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Inhalable Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Inhalable Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Inhalable Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Inhalable Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Inhalable Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Inhalable Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Inhalable Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Inhalable Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure UAE Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Inhalable Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Inhalable Drugs Sales and Growth Rate (2013-2018)
Table Global Inhalable Drugs Sales by Type (2013-2018)
Table Global Inhalable Drugs Sales Share by Type (2013-2018)
Table Global Inhalable Drugs Revenue by Type (2013-2018)
Table Global Inhalable Drugs Revenue Share by Type (2013-2018)
Figure Global Suspension Aerosol Sales Growth (2013-2018)
Figure Global Suspension Aerosol Price (2013-2018)
Figure Global Solution Aerosol Sales Growth (2013-2018)
Figure Global Solution Aerosol Price (2013-2018)
Figure Global Dry Powder Formulation Sales Growth (2013-2018)
Figure Global Dry Powder Formulation Price (2013-2018)
Table Global Inhalable Drugs Sales by Application (2013-2018)
Table Global Inhalable Drugs Sales Share by Application (2013-2018)
Figure Global Non-respiratory diseases Sales Growth (2013-2018)
Figure Global Inhalable Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Inhalable Drugs Sales Forecast by Regions (2018-2023)
Table Global Inhalable Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Inhalable Drugs Market Forecast (2018-2023)
Figure Europe Sales Inhalable Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Inhalable Drugs Market Forecast (2018-2023)
Figure South America Sales Inhalable Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Inhalable Drugs Market Forecast (2018-2023)
Table Global Inhalable Drugs Sales Forecast by Type (2018-2023)
Table Global Inhalable Drugs Market Share Forecast by Type (2018-2023)
Table Global Inhalable Drugs Sales Forecast by Application (2018-2023)
Table Global Inhalable Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...